首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: the Danish Endometrial Cancer Study (DEMCA).
【24h】

Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: the Danish Endometrial Cancer Study (DEMCA).

机译:未接受术后放疗的中度危险组中丹麦子宫内膜癌患者的生存率:丹麦子宫内膜癌研究(DEMCA)。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: In a prospective study during the years 1986 to 1988, the Danish Endometrial Cancer Group (DEMCA) demonstrated that postoperative radiotherapy was unnecessary for low-risk patients with stage I disease. In the present study, we evaluated in a population-based study if radiotherapy could also be omitted for intermediate-risk patients with stage I disease without loss of survival. STUDY DESIGN: From 1998 to 1999, 1166 patients newly diagnosed with carcinoma of the uterus were included in this prospective nationwide study. Of these, 232 were intermediate-risk patients with stage I disease. All intermediate-risk patients received standard primary surgery (hysterectomy, bilateral salpingo-oophorectomy, and peritoneal washings), and no postoperative radiotherapy was given. Survival analyses were performed using Kaplan-Meier survival estimates. The results were compared to the 1986-1988 DEMCA data. RESULTS: The 5-year overall survival (OS) rate for the entire population was 77% (stages I-IV). The patients with stage I disease were divided into low-, intermediate-, and high-risk; the OS rates were 91%, 78%, and 62%, and the endometrial cancer-specific survival rates were 97%, 87%, and 72%, respectively. Using patients' age, tumor grade, myometrial invasion, we divided the intermediate-risk group into "high risk" intermediate and "low-risk" intermediate with OS rates of 70% and 90% and cancer-specific survival of 81% and 96%, respectively. The OS rate (78%) of the intermediate-risk group after radiation had been omitted was comparable to the OS rate (79%) of the intermediate-risk group in the earlier DEMCA (1986-1988) study where postoperative radiation was still the standard of care. CONCLUSION: We conclude that in a population-based study, radiotherapy can be omitted for intermediate-risk patients with stage I endometrial cancer without loss of survival.
机译:目的:在1986年至1988年的一项前瞻性研究中,丹麦子宫内膜癌小组(DEMCA)表明,对于低风险的I期疾病患者,术后放疗是不必要的。在本研究中,我们在一项基于人群的研究中评估了是否也可以在不丧失生存能力的情况下,对I期疾病的中危患者省略放疗。研究设计:从1998年到1999年,这项前瞻性的全国性研究纳入了1166例新诊断为子宫癌的患者。其中,232例是中度I期疾病患者。所有中度风险患者均接受标准的原发手术(子宫切除术,双侧输卵管卵巢切除术和腹膜冲洗术),且未进行术后放疗。使用Kaplan-Meier生存估计进行生存分析。将结果与1986-1988年DEMCA数据进行比较。结果:整个人群的5年总生存率(OS)为77%(I-IV期)。 Ⅰ期疾病患者分为低危,中危和高危。 OS率为91%,78%和62%,子宫内膜癌特异性生存率分别为97%,87%和72%。根据患者的年龄,肿瘤分级,肌层浸润情况,我们将中危组分为“高危”中级和“低危”中级,OS率分别为70%和90%,癌症特异性生存率分别为81%和96 %, 分别。省略放射后,中危组的OS率(78%)与早期DEMCA(1986-1988)研究中的中危组的OS率(79%)相当,在早期研究中,术后放射仍是护理标准。结论:我们得出结论,在一项基于人群的研究中,对于中等风险的I期子宫内膜癌患者可以省略放疗,而不会降低生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号